An exciting series of talks provided by Visiting Professor, Chris Hancock. Hancock is a celebrated award-winning engineer and successful entrepreneur with a £350 million company on the London Stock Exchange
Exploring the intersection of Medicine, Engineering & Entrepreneurship
This talk series is organised by the Institute of Communications and Connected Systems at UCL, in collaboration with the Institute of Healthcare Engineering as part of a Royal Academy of Engineering visiting professorship.
Visiting Professor Chris Hancock will provide these exciting talks. Professor Hancock is a celebrated award-winning engineer and successful entrepreneur. His original studies, undertaken in Engineering laboratories at the UCL Institute of Communications and Connected Systems, have now led to a £350 million company on the London Stock Exchange that is using engineering to make an impactful difference to patients all of the world.
Lecture recordings now available
Professor Hancock provided his series of RAEng lectures in March 2021. Recordings of each lecture are now available via the event pages below
Chris Hancock, Royal Academy of Engineering Visiting Professor will provide this talk on applying electronic design techniques and harnessing new technology developed for other sectors to treat cancer and other diseases that will Impact all of us one day.
Chris Hancock, Royal Academy of Engineering Visiting Professor will provide this talk exploring real-life examples of new advanced treatment solutions that are now making a difference to the life of patients all over the world.
Chris Hancock, Royal Academy of Engineering Visiting Professor will provide this talk reflecting on the key ingredients required to turn an idea into a successful business that can change life.
Professor Chris Hancock
Chief Technology Officer and Founder at Creo Medical Limited
Chris Hancock received the Ph.D. degree in electronic engineering, working on electronic and microwave circuits, from Bangor University, Bangor, U.K., in 1996. From 1997 to 2002, he was a Senior Microwave Engineer with Gyrus Medical Ltd. In 2003, he founded MicroOnclogy Ltd.; which is now Creo Medical Limited, a UK based company with a market value close to £350 million. Creomedical developed Chris’s ideas, based on dynamic impedance-matching techniques and integrated RADAR measurement techniques using Ku band energy, for the treatment of tumors.
Creo’s advanced therapeutic energy therapeutic system and miniature instruments have been used now for treatment of patients worldwide for a range of cancers and has transformed the lives of many people – the aim of the company has always been to produce better patient outcomes. In 2009, he was appointed to the chair in Medical Microwave Systems at Bangor University and in 2018 he became a Royal Academy of Engineering Visiting professor at UCL. In 2019 he was awarded the Institute of Physics Katherine Burr Blodgett Gold Medal and Prize for work on the development of advanced therapeutic energy delivery systems to perform minimally invasive surgery. Chris is a Fellow of the Institute of Physics, a Chartered Physicist, Fellow of the Institute of Engineering and Technology, a Chartered Engineer and a Senior Member of the IEEE. He is a named inventor and lead author on over 1000 patents/patent applications and scholarly publications.